| inquiry@shreejipharma.com |
| +91-8866002331, +91-8758805202 |
Product Details
| Grade | IP / BP / USP |
| Therapeutic Category | Erectile dysfunction agent |
| CAS No | 224785-90-4 |
| Other Name | Levitra |
| COA | Available |
| MSDS | Available |
Preferred Buyer From
| Location | Worldwide |
Vardenafil (Vardenafil) is the world's newest disease erectile dysfunction (ED) in the field of new medications , by inhibiting phosphodiesterase type 5 (PDE-5) works.
Beyond its indications for erectile dysfunction, vardenafil may be effective in the treatment of premature ejaculation, where it may significantly increase the time from vaginal penetration to ejaculation.
Vardenafil, as with all PDE5 inhibitors, should not be used by men taking nitrate medications, because combining them with vardenafil might provoke potentially life-threatening hypotension (low blood pressure).
Specification
| Test Items | Specification | Test Results |
| Description | White or almost white crystalline powder | White crystalline powder |
| Melting Point | 191.0~193.0°C | 192°C |
| Loss of drying | ≤1.0% | 0.01 |
| Heavy Metal | ≤20ppm | 15ppm |
| TLC | Only one spot | Only one spot |
| Assay | ≥99.5% | 1 |
| Conclusion | It complies with the USP 32. | |
